Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education | NG213 | | |
MRI-based technologies for assessing non-alcoholic fatty liver disease | DG50 | | |
Transcutaneous electrical stimulation of the trigeminal nerve for ADHD | IPG748 | | |
Laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux disease | IPG749 | | |
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma | TA857 | | |
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma | TA858 | | |
PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis | MIB313 | | |
Chronic heart failure in adults | QS9 | | |
Diabetes in pregnancy | QS109 | | |
Hip fracture: management | CG124 | | |
Hip fracture in adults | QS16 | | |
Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain | IPG747 | | |
Upadacitinib for treating moderately to severely active ulcerative colitis | TA856 | | |
Thyroid cancer: assessment and management | NG230 | | |
Tobacco: treating dependence | QS207 | | |
Avatrombopag for treating primary chronic immune thrombocytopenia | TA853 | | |
Fetal monitoring in labour | NG229 | | |
Cabozantinib for previously treated advanced hepatocellular carcinoma | TA849 | | |
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy | TA850 | | |
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer | TA851 | | |
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments | TA852 | | |
Esketamine nasal spray for treatment-resistant depression | TA854 | | |
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes | MIB312 | | |
Memokath 051 Ureter stent for ureteric obstruction | MTG75 | | |
Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal) | TA848 | | |
Optilume for treating recurrent bulbar urethral strictures | MTG73 | | |
GreenLight XPS for treating benign prostatic hyperplasia | MTG74 | | |
Mepolizumab for treating eosinophilic granulomatosis with polyangiitis (terminated appraisal) | TA845 | | |
Mepolizumab for treating severe hypereosinophilic syndrome (terminated appraisal) | TA846 | | |
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal) | TA847 | | |
Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal) | TA843 | | |
Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal) | TA844 | | |
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis | IPG746 | | |
Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management | NG228 | | |
Fractures (complex): assessment and management | NG37 | | |
Ab interno canaloplasty for open-angle glaucoma | IPG745 | | |
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal) | TA842 | | |
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA841 | | |
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules | IPG743 | | |
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids
(terminated appraisal) | TA840 | | |
Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder | IPG742 | | |
Advocacy services for adults with health and social care needs | NG227 | | |
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal) | TA838 | | |
Digital technologies for the detection of melanoma | MIB311 | | |
Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine | IPG740 | | |
YAG laser vitreolysis for symptomatic vitreous floaters | IPG741 | | |
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy | TA836 | | |
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma | TA837 | | |
Osteoarthritis in over 16s: diagnosis and management | NG226 | | |
Osteoarthritis in over 16s | QS87 | | |